UB Paderborn / Katalog / Suche / in CDI

26 – 50 von 54

Sortiert nach

Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial

BMJ (Online), 2010-05, Vol.340, p.c2181

2010

Volltextzugriff (PDF)

14-LB: Finerenone in Patients with CKD and T2D by SGLT2i Treatment: An Analysis of the FIDELIO-DKD Study

Diabetes (New York, N.Y.), 2021-06, Vol.70 (Supplement_1)

2021

Volltextzugriff (PDF)

Long‐term treatment with metformin in type 2 diabetes and vitamin D levels: A post‐hoc analysis of a randomized placebo‐controlled trial

Diabetes, obesity & metabolism, 2018-08, Vol.20 (8), p.1951-1956

2018

Volltextzugriff (PDF)

A gene variant near ATM affects the response to metformin and metformin plasma levels: a post hoc analysis of an RCT

Pharmacogenomics, 2018-06, Vol.19 (8), p.715-726

2018

Volltextzugriff (PDF)

Hypoglycemie bij diabetes tijdens ziekenhuisopname: relevant voor klinische uitkomsten?

Nederlands Tijdschrift voor Diabetolog, 2011-12, Vol.9 (4), p.185-192

Kooy, Adriaan

2011

Volltextzugriff (PDF)

Hypoglycemie bij diabetes: relevant voor het cardiovasculaire risico en de cognitie?: Een actueel overzicht van reële associaties en mogelijke consequenties

Nederlands Tijdschrift voor Diabetolog, 2011-09, Vol.9 (2), p.52-61

Kooy, Adriaan

2011

Volltextzugriff (PDF)

1101-P: Cardiorenal Outcomes with Dapagliflozin by Baseline Glucose Lowering Agents: Analyses from DECLARE-TIMI 58

Diabetes (New York, N.Y.), 2020-06, Vol.69 (Supplement_1)

2020

Volltextzugriff (PDF)

Pregnancy Outcomes: Effects of Metformin (POEM) study: a protocol for a long-term, multicentre, open-label, randomised controlled trial in gestational diabetes mellitus

BMJ open, 2022-03, Vol.12 (3), p.e056282-e056282

2022

Volltextzugriff (PDF)

Long-term treatment with metformin in type 2 diabetes and methylmalonic acid: Post hoc analysis of a randomized controlled 4.3year trial

Journal of diabetes and its complications, 2018-02, Vol.32 (2), p.171-178

2018

Volltextzugriff (PDF)

Metformin‐associated prevention of weight gain in insulin‐treated type 2 diabetic patients cannot be explained by decreased energy intake: A post hoc analysis of a randomized placebo‐controlled 4.3‐year trial

Diabetes, obesity & metabolism, 2018-01, Vol.20 (1), p.219-223

2018

Volltextzugriff (PDF)

Presence of retinopathy and incident kidney and cardiovascular events in type 2 diabetes with normoalbuminuria – A post-hoc analysis of the PRIORITY randomized clinical trial

Journal of diabetes and its complications, 2023-04, Vol.37 (4), p.108433-108433, Article 108433

2023

Volltextzugriff (PDF)

Effects of short‐term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo‐controlled trial

Journal of internal medicine, 2005-01, Vol.257 (1), p.100-109

2005

Volltextzugriff (PDF)

Cohort profile: the ‘Biomarkers of heterogeneity in type 1 diabetes’ study—a national prospective cohort study of clinical and metabolic phenotyping of individuals with long-standing type 1 diabetes in the Netherlands

BMJ open, 2024-06, Vol.14 (6), p.e082453

2024

Volltextzugriff (PDF)

Endothelial dysfunction and low-grade inflammation explain much of the excess cardiovascular mortality in individuals with type 2 diabetes: the Hoorn Study

Arteriosclerosis, thrombosis, and vascular biology, 2006-05, Vol.26 (5), p.1086

2006

Volltextzugriff (PDF)

Gastrointestinal symptoms and association with medication use patterns, adherence, treatment satisfaction, quality of life, and resource use in osteoporosis: baseline results of the MUSIC-OS study

Osteoporosis international, 2016-03, Vol.27 (3), p.1227-1238

2016

Volltextzugriff (PDF)

The Role of Self-Regulation in the Effect of Self-Tracking of Physical Activity and Weight on BMI

Journal of technology in behavioral science, 2020-06, Vol.5 (2), p.206-214

2020

Volltextzugriff (PDF)

Long-term effects of metformin on metabolism and microvascular and macrovascular disease in patients with type 2 diabetes mellitus

Archives of internal medicine (1960), 2009-03, Vol.169 (6), p.616

2009

Volltextzugriff (PDF)

Reductions in A1C with pump therapy in type 2 diabetes are independent of C-peptide and anti-glutamic acid decarboxylase antibody concentrations

Diabetes technology & therapeutics, 2014-11, Vol.16 (11), p.816

2014

Volltextzugriff (PDF)

De effecten van metformine op het metabolisme en het optreden van cardiovasculaire ziekte bij patiënten met type 2 diabetes: Winnaar van de 25e Dr. F. Gerritzenprijs voor het beste proefschrift op het gebied van diabetes onderzoek

Nederlands Tijdschrift voor Diabetolog, 2011-05, Vol.9 (1), p.18-23

2011

Volltextzugriff (PDF)

Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial

BMJ. British medical journal (International ed.), 2010-05, Vol.340 (7757), p.1177

International edition, 2010

Volltextzugriff (PDF)

Review wetenschappelijk congres American Diabetes Association

Nederlands Tijdschrift voor Diabetolog, 2013-09, Vol.11 (3), p.73-73

Kooy, A.

2013

Volltextzugriff (PDF)

Prevalence and risk factors of depression and diabetes- related emotional distress in patients with type 2 diabetes: A cross-sectional study

Journal of nursing education and practice, 2012-12, Vol.3 (6)

2012

Volltextzugriff (PDF)

Does metformin decrease blood pressure in patients with Type 2 diabetes intensively treated with insulin?

Diabetic medicine, 2005-07, Vol.22 (7), p.907-913

2005

Volltextzugriff (PDF)

Evidence for the involvement of corticotropin-releasing factor in the inhibition of gonadotropin release induced by hyperprolactinemia

Neuroendocrinology, 1990, Vol.51 (3), p.261

1990

Volltextzugriff (PDF)

Long Term Treatment with Metformin in Patients with Type 2 Diabetes and Risk of Vitamin B-12 Deficiency: Randomized Placebo Controlled Trial

BMJ (British Medical Journal), 2010-05, Vol.340 (7757), p.1177-1177

2010

Volltextzugriff (PDF)

26 – 50 von 54

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(54)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(34)
Life Sciences & Biomedicine
(33)
Diabetes
(30)
Humans
(25)
Diabetes Mellitus, Type 2 - Drug Therapy
(19)
Endocrinology & Metabolism
(18)
Insulin
(17)
Diabetes Mellitus
(16)
Female
(16)
Metformin
(16)
Male
(15)
Middle Aged
(15)
Aged
(12)
Antidiabetics
(11)
Cardiovascular Disease
(11)
Hypoglycemic Agents - Therapeutic Use
(11)
Clinical Trials
(10)
Adult
(9)
Biological And Medical Sciences
(9)
Diabetes Mellitus, Type 2 - Blood
(9)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial

14-LB: Finerenone in Patients with CKD and T2D by SGLT2i Treatment: An Analysis of the FIDELIO-DKD Study

Long‐term treatment with metformin in type 2 diabetes and vitamin D levels: A post‐hoc analysis of a randomized placebo‐controlled trial

A gene variant near ATM affects the response to metformin and metformin plasma levels: a post hoc analysis of an RCT

Hypoglycemie bij diabetes tijdens ziekenhuisopname: relevant voor klinische uitkomsten?

Hypoglycemie bij diabetes: relevant voor het cardiovasculaire risico en de cognitie?: Een actueel overzicht van reële associaties en mogelijke consequenties

1101-P: Cardiorenal Outcomes with Dapagliflozin by Baseline Glucose Lowering Agents: Analyses from DECLARE-TIMI 58

Pregnancy Outcomes: Effects of Metformin (POEM) study: a protocol for a long-term, multicentre, open-label, randomised controlled trial in gestational diabetes mellitus

Long-term treatment with metformin in type 2 diabetes and methylmalonic acid: Post hoc analysis of a randomized controlled 4.3year trial

Metformin‐associated prevention of weight gain in insulin‐treated type 2 diabetic patients cannot be explained by decreased energy intake: A post hoc analysis of a randomized placebo‐controlled 4.3‐year trial

Presence of retinopathy and incident kidney and cardiovascular events in type 2 diabetes with normoalbuminuria – A post-hoc analysis of the PRIORITY randomized clinical trial

Effects of short‐term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo‐controlled trial

Cohort profile: the ‘Biomarkers of heterogeneity in type 1 diabetes’ study—a national prospective cohort study of clinical and metabolic phenotyping of individuals with long-standing type 1 diabetes in the Netherlands

Endothelial dysfunction and low-grade inflammation explain much of the excess cardiovascular mortality in individuals with type 2 diabetes: the Hoorn Study

Gastrointestinal symptoms and association with medication use patterns, adherence, treatment satisfaction, quality of life, and resource use in osteoporosis: baseline results of the MUSIC-OS study

The Role of Self-Regulation in the Effect of Self-Tracking of Physical Activity and Weight on BMI

Long-term effects of metformin on metabolism and microvascular and macrovascular disease in patients with type 2 diabetes mellitus

Reductions in A1C with pump therapy in type 2 diabetes are independent of C-peptide and anti-glutamic acid decarboxylase antibody concentrations

De effecten van metformine op het metabolisme en het optreden van cardiovasculaire ziekte bij patiënten met type 2 diabetes: Winnaar van de 25e Dr. F. Gerritzenprijs voor het beste proefschrift op het gebied van diabetes onderzoek

Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial

Review wetenschappelijk congres American Diabetes Association

Prevalence and risk factors of depression and diabetes- related emotional distress in patients with type 2 diabetes: A cross-sectional study

Does metformin decrease blood pressure in patients with Type 2 diabetes intensively treated with insulin?

Evidence for the involvement of corticotropin-releasing factor in the inhibition of gonadotropin release induced by hyperprolactinemia

Long Term Treatment with Metformin in Patients with Type 2 Diabetes and Risk of Vitamin B-12 Deficiency: Randomized Placebo Controlled Trial

Suchergebnisse filtern